Ads
related to: cancer cell types
Search results
Race Oncology higher as bisantrene is combined with decitabine to enhance killing of multiple cancer...
Proactive Investors· 10 hours agoRace Oncology Ltd (ASX:RAC, OTC:RAONF) is trading higher on findings that combining bisantrene with...
Race Oncology's breakthrough in cancer cell treatment
Proactive Investors· 7 hours agoRace Oncology Ltd (ASX:RAC, OTC:RAONF) CEO Dr Daniel Tillett joins Proactive’s Jonathan Jackson to...
Doctor ‘brain cancer-free for a year’ after undergoing own breakthrough therapy
PA Media: Science via Yahoo News· 4 hours agoProfessor Richard Scolyer was diagnosed with incurable grade 4 brain cancer after becoming ill in...
Richard Scolyer: Top doctor remains brain cancer-free after a year
BBC via Yahoo News· 2 hours ago"We've generated a whole heap of data, to then make a foundation for that next step, so that we can...
Inside the Cellular Tug-of-War: What Drives Cancer’s Spread?
SciTechDaily· 7 days agoIn a paper published today in APL Bioengineering, by AIP Publishing, a team of researchers from...
Pancreatic cancer: Symptoms, causes and treatment
The Telegraph via Yahoo News· 5 days agoAs one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread which surrounds the disease.
Researchers identify what drives PARP inhibitor resistance in advanced breast cancer
Medical Xpress· 6 days agoPARP inhibitors are a type of targeted therapy that is used to treat breast cancers with a faulty BRCA1 or BRCA2 gene. Cancer cells with mutations in the BRCA1/2 genes are ...
Self-proclaimed Star Trek physicist raises $16M to develop holographic cancer treatment
Crain's New York Business· 4 days agoPrior to its $16 million-fundraise, Holobeam raised $100,000 in 2018 from a group of investors including Dr. Kenneth Hall, a surgeon who sits on its board, and Jeff Studley, the founder of CPR ...
Supercharging immune cells to battle blood cancer: Advances in cancer immunotherapy
Medical Xpress· 5 days agoCD300A, a type-I transmembrane protein with immunoreceptor tyrosine-based inhibitory motifs, emerges as a potential immune checkpoint, negatively regulating NK cell function ...
Cancer doctor reveals remarkable results after undergoing own breakthrough treatment
The Independent via Yahoo News· 7 hours agoMr Scolyer was diagnosed with "the worst of the worst" type of brain cancer in June last year and...
